Introduction of miR-34b/c into cancer cells leads to the downregulation of candidate target genes, including MET, CDK4, cyclin E2 (CCNE2), and MYC (Lujambio et al., 2008; Toyota et al., 2008). This evidence concerns the gene CCNE2 and cancer.